Author:
Salih Julia,Hilpert Julia,Placke Theresa,Grünebach Frank,Steinle Alexander,Salih Helmut Rainer,Krusch Matthias
Reference38 articles.
1. Translation of the Philadelphia chromosome into therapy for CML;Druker;Blood,2008
2. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia;Cohen;Clin Cancer Res,2002
3. International randomized study of interferon versus STI571 (IRIS) 7-year follow-up: sustained survival, low rate of transformation and increased rate of major molecular response (MMR) in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CMLCP) treated with Imatinib (IM);O'Brien;ASH Annu Meet Abstr,2008
4. Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia;Weisberg;Nat Rev Cancer,2007
5. Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL;Kantarjian;N Engl J Med,2006